Ypsomed

8 articles about Ypsomed

• Viridian Therapeutics Enters Autoinjector Pen Device Customization and Supply Agreement with Ypsomed AG for Subcutaneous Drug Delivery in Thyroid Eye Disease

  10/26/2023

  Viridian Therapeutics, Inc. and Ypsomed AG (SIX: YPSN), the leading developer and manufacturer of injection and infusion systems for self-medication have signed a supply agreement for Ypsomed’s customizable YpsoMate 2.25 autoinjector pen device with a fill volume of 2.0 milliliters.

• Civica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiative

  1/31/2023

  Civica, Inc. (Civica, Civica Rx) today announced the selection of Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for Civica’s affordable insulins.

• LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM

  11/7/2022

  Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the pen injector device to be used in connection with its biosimilar insulin glargine and biosimilar insulin aspart development programs.

• Bigfoot Biomedical and Ypsomed Announce Agreement

  10/25/2017

  Bigfoot Biomedical and Ypsomed announced that the companies have entered into an agreement under which Ypsomed will supply Bigfoot with a customized proprietary version of its Orbit infusion sets as part of Bigfoot’s investigational automated insulin pump-based solution for use in a pivotal trial.

• Ypsomed Tanks as Insulet Decides Not to Extend Omnipod Agreement in 2018

  7/21/2017

• Ypsomed To Make Diabetes Injection Pens In China

  12/17/2014

• Insulet Corporation Expands International Distribution Partnership With Ypsomed

  4/12/2012

• Insulet Corporation and Ypsomed Sign International Distribution Agreement for the OmniPod Insulin Management System

  1/5/2010